Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection-Reference-Cited by-同舟云学术

Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection

Published:2007-02 Issue:1 Volume:32 Page:57-65
ISSN:1080-0549
Container-title:Clinical Reviews in Allergy & Immunology
language:en
Short-container-title:Clinic Rev Allerg Immunol

Author:

Warger Tobias,Rechtsteiner Gerd,Schmid Beate,Osterloh Philipp,Schild Hansjörg,Radsak Markus P.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF02686082.pdf

Reference30 articles.

1. Danaei, G., Vander, H. S., Lopez, A. D., Murray, C. J., and Ezzati, M. (2005), Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366, 1784–1793.

2. Kaech, S. M., Wherry, E. J., and Ahmed R. (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2, 251–262.

3. Dudley, M. E. and Rosenberg, S. A. (2003) Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 3, 666–675.

4. Dudley, M. E., Nishimura, M. I., Holt, A. K., and Rosenberg, S. A. (1999) Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL response. J. Immunother. 22, 288–298.

5. Rosenberg, S. A., Yang, J. C., and Restifo, N. P. (2004), Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10, 909–915.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microneedle-enhanced drug delivery: fabrication, characterization, and insights into release and permeation of nanocrystalline imiquimod;Frontiers in Drug Delivery;2024-06-27

2. Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice;European Journal of Immunology;2019-08-19

3. Novel imiquimod nanovesicles for topical vaccination;Colloids and Surfaces B: Biointerfaces;2019-02

4. Mediators of Inflammation in Topical Therapy of Skin Cancers;Mediators of Inflammation;2019-01-10

5. Make It Simple: (SR-A1+TLR7) Macrophage Targeted NANOarchaeosomes;Frontiers in Bioengineering and Biotechnology;2018-11-06